Hepatitis C in Brazil: lessons learned with boceprevir and telaprevir-Reference-Cited by-同舟云学术

Hepatitis C in Brazil: lessons learned with boceprevir and telaprevir

Published:2018-06-28 Issue:0 Volume:60 Page:
ISSN:1678-9946
Container-title:Revista do Instituto de Medicina Tropical de São Paulo
language:
Short-container-title:Rev. Inst. Med. trop. S. Paulo

Author:

Gomes Lenyta Oliveira¹,Teixeira Marina Rodrigues¹,Rosa Júnior André da¹,Feltrin Alberi Adolfo²,Rodrigues João Paulo V.³,Vecchi Mariane D’Avila⁴,Carneiro Jane Meire M.⁵,Noblat Lúcia de Araújo C. B.⁵,Chachá Silvana Gama F.⁶,Martinelli Ana de Lourdes C.³,Pereira Leonardo Regis L.³,Silveira Marysabel Pinto T.⁴,Blatt Carine Raquel⁷,Farias Mareni Rocha¹

Affiliation:

1. Universidade Federal de Santa Catarina, Brazil

2. Hospital Nossa Senhora da Conceição, Brazil

3. Universidade de São Paulo, Brazil

4. Universidade Federal de Pelotas, Brazil

5. Universidade Federal da Bahia, Brazil

6. Universidade Federal de São Carlos, Brazil; Universidade de São Paulo, Brazil

7. Universidade Federal de Ciências da Saúde de Porto Alegre, Brazil

Publisher

FapUNIFESP (SciELO)

Link

http://www.scielo.br/pdf/rimtsp/v60/1678-9946-rimtsp-60-S1678-9946201860029.pdf

Reference35 articles.

1. Drugs@FDA: FDA approved drug products : Victrelis

2. Drugs@FDA: FDA approved drug products : Incivek

3. A population approach to disease management: hepatitis C direct-acting antiviral use in a large health care system;Belperio PS;J Manag Care Spec Pharm,2014

4. Treatment patterns, health care resource utilization, and costs in U.S. patients diagnosed with chronic hepatitis C infection who received telaprevir or boceprevir;Le TK;J Manag Care Spec Pharm,2015

5. Inibidores de protease (Boceprevir e Telaprevir) para o tratamento da hepatite crônica C: relatório de recomendação da Comissão Nacional de Incorporação de Tecnologias no SUS – CONITEC – 01,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost and Effectiveness of the Treatment of Chronic Hepatitis C in Brazil: Real-World Data;Value in Health Regional Issues;2020-12